Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-88.21%
operating margin TTM
-82.61%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.92 |
| peg ratio | -0.03 |
| price to book ratio | 0.44 |
| price to sales ratio | 1.70 |
| enterprise value multiple | -5.90 |
| price fair value | 0.44 |
profitability ratios | |
|---|---|
| gross profit margin | 98.0% |
| operating profit margin | -82.61% |
| pretax profit margin | -87.73% |
| net profit margin | -88.21% |
| return on assets | -21.0% |
| return on equity | -21.0% |
| return on capital employed | -21.46% |
liquidity ratio | |
|---|---|
| current ratio | 11.46 |
| quick ratio | 11.46 |
| cash ratio | 9.25 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 15.91 |
| days of payables outstanding | 259.05 |
| cash conversion cycle | -243.14 |
| receivables turnover | 22.95 |
| payables turnover | 1.41 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -2,072.63 |
| cash flow to debt ratio | -139.42 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.46 |
| cash per share | 1.70 |
| operating cash flow per share | -0.45 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -139.42 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -55.85 |
Frequently Asked Questions
When was the last time Connect Biopharma Holdings Limited (NASDAQ:CNTB) reported earnings?
Connect Biopharma Holdings Limited (CNTB) published its most recent earnings results on 30-06-2024.
What is Connect Biopharma Holdings Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Connect Biopharma Holdings Limited (NASDAQ:CNTB)'s trailing twelve months ROE is -21.0%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Connect Biopharma Holdings Limited (CNTB) currently has a ROA of -21.0%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CNTB's net profit margin stand at?
CNTB reported a profit margin of -88.21% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CNTB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 11.46 in the most recent quarter. The quick ratio stood at 11.46, with a Debt/Eq ratio of 0.00.